drugset / Trial / NCT00422617
Evaluate the Efficacy and Safety of One Course of Amevive in Taiwan Patients
Non-randomizedSingle-groupOpen-labelEct
Summary
An open-label, multicentre study to evaluate the efficacy and safety of one course of weekly intramuscular administration of Amevive in Taiwan patients with chronic plaque psoriasis
Timeline
- Start
- 2005-01
- Primary completion
- —
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alefacept | Protein / enzyme biologic | 15 mg | Intramuscular |